# MucoLife Therapeutics

**Source:** https://www.startuphub.ai/startups/mucolife-therapeutics
**Profile type:** Startup

> Developing first-in-class inhaled peptides to dissolve airway mucus plugs in COPD and other chronic lung diseases.

## About

MucoLife Therapeutics is a biotechnology company pioneering innovative inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD, cystic fibrosis, asthma, and bronchiectasis. Their lead product, MLT-001, is a patented first-in-class mucus modulator designed to directly dissolve airway mucus plugs, aiming to improve lung function and prevent chronic inflammation and infections. The company leverages over 40 years of research in mucin biology from the University of Gothenburg.

## Key facts

- **Slug:** mucolife-therapeutics
- **Website:** https://mucolife.com
- **Location:** Gothenburg, Sweden
- **Founded:** 2024-01-01
- **Employees:** 1
- **Operating status:** Active
- **Total funding:** $98K
- **Sectors / tags:** Biotechnology, Life Sciences, Healthcare, Biotech, MedTech
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/mucolife
  - Facebook: http://www.facebook.com/2008

## StartupHub.ai scores

- **Ahrefs DR:** 1/100
- **Effective DR:** 16/100
- **Agent Readiness:** C (67/100)
- **Site Speed:** 52/100
- **Data Trust:** 72/100

## Funding rounds

| Date | Round | Amount | Lead investors |
| --- | --- | --- | --- |
| 6 Nov 2026 | [Grant](https://www.startuphub.ai/investment_rounds/mucolife-therapeutics-grant-2026) | $98K | - |

## Tech stack

Detected on mucolife.com, last scanned 2026-11-06.

- **CMS / Builders:** Squarespace
- **Affiliate program:** Self-hosted affiliate

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "MucoLife Therapeutics",
          "item": "https://www.startuphub.ai/startups/mucolife-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/mucolife-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/mucolife-therapeutics",
      "name": "MucoLife Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the StartupHub.ai profile of MucoLife Therapeutics. MucoLife Therapeutics is a startup founded in 2024, operating in Biotechnology and Life Sciences. Developing first-in-class inhaled peptides to dissolve airway mucus plugs in COPD and other chronic lung diseases. Headquartered in Gothenburg, Sweden. The company has approximately 1 employees.",
      "dateModified": "2026-11-06T15:10:19.762Z",
      "mainEntity": {
        "@type": "Organization",
        "@id": "https://www.startuphub.ai/startups/mucolife-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/mucolife-therapeutics#organization",
      "name": "MucoLife Therapeutics",
      "url": "https://mucolife.com",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/3135045a-e834-4f50-bc67-7b223ec64cc2-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/3135045a-e834-4f50-bc67-7b223ec64cc2-square.webp",
      "description": "MucoLife Therapeutics is a biotechnology company pioneering innovative inhaled therapies for pulmonary mucus obstruction in chronic lung diseases such as COPD, cystic fibrosis, asthma, and bronchiectasis. Their lead product, MLT-001, is a patented first-in-class mucus modulator designed to directly dissolve airway mucus plugs, aiming to improve lung function and prevent chronic inflammation and infections. The company leverages over 40 years of research in mucin biology from the University of Gothenburg.",
      "sameAs": [
        "https://www.linkedin.com/company/mucolife",
        "http://www.facebook.com/2008"
      ],
      "foundingDate": "2024-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 1
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Gothenburg",
        "addressCountry": "Sweden"
      },
      "knowsAbout": [
        "Biotechnology",
        "Life Sciences",
        "Healthcare",
        "Biotech",
        "MedTech"
      ]
    }
  ]
}
```